[ad_1]
Good news from Brussels. The European Union could give the green light to the sale of Pfizer and Moderna vaccines in the second half of December. He says so The president of the European Commission, Ursula von der Leyen, says that everything depends on the results of the evaluation of the two by the European Medicines Agency.COVID-19.
The head of the European Commission recalls that the Union has clashed with 5 producers ofCOVID-19. The advantage is that the serums use 4 different technologies that could be effective for various segments of the population.
„The EMA (European Medicines Agency) is in daily contact with the FDA (similar body in the United States) to synchronize the evaluation of the vaccines and, if all goes well, the EMA says that the marketing authorization of the vaccines could be issued Biontech and Moderna. in the second half of December 2020”, A spus Von der Leyen.
„We have entered into 5 contracts with BionTech, CureVac, Astra / Zeneca, Johnson & Johnson, and Sanofi. We are continuing negotiations with Moderna and are in talks with Novavax. It was gratifying to see that all Member States have agreed to buy these vaccines and stay in our portfolio. This portfolio of 5 vaccines, hopefully 6 soon, is important because it covers four different production technologies. Some vaccines may work better in some parts of the population than othersShe added.
Editing: Monica Bonea
